Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Javle

Showing results (41-50 of 99) with videos related to

Pageof 10
Sort By:
Cancer|November 10, 2004
Risk factors associated with earlier age of onset in familial pancreatic carcinomaTed A James, David G Sheldon, Ashwani Rajput, et al.
Journal of Gastrointestinal Oncology|November 12, 2025
Ethnic and socioeconomic disparities in survival outcomes among patients under 65 years with intrahepatic cholangiocarcinoma: a SEER analysisAdit Dharia, Lianchun Xiao, Janak Abraham, et al.
Anticancer Research|October 23, 2009
High-dose octreotide acetate for management of gastroenteropancreatic neuroendocrine tumorsManpreet K Chadha, Jeffrey Lombardo, Terry Mashtare, et al.
Cancer Chemotherapy and Pharmacology|October 27, 2006
Phase I study of weekly DN-101, a new formulation of calcitriol, in patients with cancerTomasz M Beer, Milind M Javle, Christopher W Ryan, et al.
Annals of Surgical Oncology|June 22, 2006
Activated Akt and Erk expression and survival after surgery in pancreatic carcinomaKrishdeep S Chadha, Thaer Khoury, Jihnhee Yu, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 15, 2016
Biologic mesh spacer placement facilitates safe delivery of dose-intense radiation therapy: A novel treatment option for unresectable liver tumorsH N Ismael, J Denbo, S Cox, et al.
BMC Cancer|July 16, 2010
Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studiesMilind M Javle, Rachna T Shroff, Henry Xiong, et al.
JCO Global Oncology|December 19, 2025
Genomic Profiling of Indian Gallbladder Carcinoma: Mutational Insights in a High-Incidence PopulationMoushumi Suryavanshi, Vikas Ostwal, Milind M Javle, et al.
Oncology|May 15, 2008
Epidermal growth factor receptor-directed therapy in esophageal cancerA U Pande, R V Iyer, A Rani, et al.
Oncogene|August 29, 2012
Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinomaN Kunkeaw, S H Jeon, K Lee, et al.
Pageof 10

Showing results (41-50 of 99) with videos related to

Sort By:
Pageof 10
Cancer|November 10, 2004
Risk factors associated with earlier age of onset in familial pancreatic carcinomaTed A James, David G Sheldon, Ashwani Rajput, et al.
Journal of Gastrointestinal Oncology|November 12, 2025
Ethnic and socioeconomic disparities in survival outcomes among patients under 65 years with intrahepatic cholangiocarcinoma: a SEER analysisAdit Dharia, Lianchun Xiao, Janak Abraham, et al.
Anticancer Research|October 23, 2009
High-dose octreotide acetate for management of gastroenteropancreatic neuroendocrine tumorsManpreet K Chadha, Jeffrey Lombardo, Terry Mashtare, et al.
Cancer Chemotherapy and Pharmacology|October 27, 2006
Phase I study of weekly DN-101, a new formulation of calcitriol, in patients with cancerTomasz M Beer, Milind M Javle, Christopher W Ryan, et al.
Annals of Surgical Oncology|June 22, 2006
Activated Akt and Erk expression and survival after surgery in pancreatic carcinomaKrishdeep S Chadha, Thaer Khoury, Jihnhee Yu, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 15, 2016
Biologic mesh spacer placement facilitates safe delivery of dose-intense radiation therapy: A novel treatment option for unresectable liver tumorsH N Ismael, J Denbo, S Cox, et al.
BMC Cancer|July 16, 2010
Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studiesMilind M Javle, Rachna T Shroff, Henry Xiong, et al.
JCO Global Oncology|December 19, 2025
Genomic Profiling of Indian Gallbladder Carcinoma: Mutational Insights in a High-Incidence PopulationMoushumi Suryavanshi, Vikas Ostwal, Milind M Javle, et al.
Oncology|May 15, 2008
Epidermal growth factor receptor-directed therapy in esophageal cancerA U Pande, R V Iyer, A Rani, et al.
Oncogene|August 29, 2012
Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinomaN Kunkeaw, S H Jeon, K Lee, et al.
Pageof 10